Banking

 

 

Fellow Outlaws,

 

Today's alert is DECN 

 

 DECN is a OTCQB stock, with only 11.5 million shares outstanding.

DECN product is called Genstrip, which was approved by the FDA on Nov. 30, 2012; it’s an alternative after-market diagnostic that’s substantially equivalent to one of J&J’s lucrative products in its medical device and diagnostic unit – a glucose monitoring system meter and diagnostic, called LifeScan Ultra, of which J&J has sold nearly $5 bill worldwide in almost a decade in the growing glucose monitoring market.

 

DECN's 10-Q notes that the Company was approached by the largest retailer in the world, recently revealed to be Wal-Mart by DECN President and CFO Keith Berman, regarding the sale of GenStrip at its 5,000+ stores globally. 

DECN is going to make waves in the diabetes testing market, and is surely going to be a contender in the near and long term

 

 

 

 

 

 

We have not received any form of compensation for this email

 

 

 

 

 

 

 

 

 

 

 

 

Can't See? [ View On Web ]   [ Unsubscribe ]   [ Report Unsolicited ]     Intelligent Email Marketing by   [ DirectIQ ]